AGEN
Price
$0.83
Change
+$0.05 (+6.41%)
Updated
Dec 4, 6:59 PM EST
100 days until earnings call
ATRA
Price
$0.70
Change
+$0.05 (+7.69%)
Updated
Dec 4, 6:59 PM EST
84 days until earnings call
Ad is loading...

Analysis and predictions AGEN vs ATRA

Header iconAGEN vs ATRA Comparison
Open Charts AGEN vs ATRABanner chart's image
Agenus
Price$0.83
Change+$0.05 (+6.41%)
Volume$6.32M
CapitalizationN/A
Atara Biotherapeutics
Price$0.70
Change+$0.05 (+7.69%)
Volume$1.19M
CapitalizationN/A
View a ticker or compare two or three
AGEN vs ATRA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AGEN vs. ATRA commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and ATRA is a Buy.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (AGEN: $0.83 vs. ATRA: $0.70)
Brand notoriety: AGEN and ATRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 128% vs. ATRA: 42%
Market capitalization -- AGEN: $251.9M vs. ATRA: $64.28M
AGEN [@Biotechnology] is valued at $251.9M. ATRA’s [@Biotechnology] market capitalization is $64.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s).

  • AGEN’s FA Score: 0 green, 5 red.
  • ATRA’s FA Score: 0 green, 5 red.
According to our system of comparison, AGEN is a better buy in the long-term than ATRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while ATRA’s TA Score has 5 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 4 bearish.
  • ATRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ATRA is a better buy in the short-term than AGEN.

Price Growth

AGEN (@Biotechnology) experienced а +25.93% price change this week, while ATRA (@Biotechnology) price change was +11.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.40%. For the same industry, the average monthly price growth was +26.79%, and the average quarterly price growth was +25.75%.

Reported Earning Dates

AGEN is expected to report earnings on Mar 14, 2024.

ATRA is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+5.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AGEN with price predictions.
OPEN
A.I.dvisor published
a Summary for ATRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AGEN($252M) has a higher market cap than ATRA($64.3M). AGEN YTD gains are higher at: -64.694 vs. ATRA (-78.649). AGEN has higher annual earnings (EBITDA): -201.61M vs. ATRA (-333.73M). AGEN (106M) and ATRA (102M) have equal amount of cash in the bank . ATRA has less debt than AGEN: ATRA (61.8M) vs AGEN (89M). AGEN has higher revenues than ATRA: AGEN (101M) vs ATRA (4.54M).
AGENATRAAGEN / ATRA
Capitalization252M64.3M392%
EBITDA-201.61M-333.73M60%
Gain YTD-64.694-78.64982%
P/E Ratio12.89N/A-
Revenue101M4.54M2,224%
Total Cash106M102M104%
Total Debt89M61.8M144%
FUNDAMENTALS RATINGS
AGEN vs ATRA: Fundamental Ratings
AGEN
ATRA
OUTLOOK RATING
1..100
910
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8495
P/E GROWTH RATING
1..100
58100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (78) in the Biotechnology industry is in the same range as AGEN (97). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

ATRA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

ATRA's SMR Rating (100) in the Biotechnology industry is in the same range as AGEN (100). This means that ATRA’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (84) in the Biotechnology industry is in the same range as ATRA (95). This means that AGEN’s stock grew similarly to ATRA’s over the last 12 months.

AGEN's P/E Growth Rating (58) in the Biotechnology industry is somewhat better than the same rating for ATRA (100). This means that AGEN’s stock grew somewhat faster than ATRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENATRA
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRET0.23N/A
N/A
Pennsylvania Real Estate Investment Trust
FFMGF0.10N/A
-0.70%
First Mining Gold Corp
KGFHY5.72-0.05
-0.87%
Kingfisher plc
NSANY7.73-0.31
-3.82%
Nissan Motor Co Ltd
NTDOF45.12-2.06
-4.37%
Nintendo Co Ltd